Latest Breaking News On - Samit hirawat - Page 1 : comparemela.com

Supply constraints force pause of BMS, RayzeBio cancer study

Thanks to a shortage of the isotope actinium, RayzeBio has temporarily halted new patient enrollment in its phase 3 study in neuroendocrine tumors.

Bristol's $250,000 Pill Slows Lung Cancer Growth by Seven Weeks

ASCO: BMS' KRAS confirmatory data leave FDA prospect unclear

Although Krazati showed a statistically significant benefit in PFS, the FDA might question its clinical meaningfulness.

Bristol Myers: presents over 130 studies at ASCO

Bristol Myers Squibb is presenting data from more than 130 studies on 25 types of cancer and serious blood disorders at ASCO and EHA.The group has announced the presentation of data from its oncology.

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting